Swiss Pharma Stock News

ABB (SWX:ABBN) has caught fresh attention after winning a Canadian Space Agency contract for lunar spectrometry work and teaming up with HDF Energy on megawatt scale hydrogen fuel cells for ships. See our latest analysis for ABB. These space and hydrogen milestones come after a steady run in the stock, with the latest share price at CHF 58.4, a solid year to date share price return of 18.8 percent and a powerful five year total shareholder return of 186.46 percent. This suggests momentum is...

EPIC Suisse (SWX:EPIC) has just raised CHF 70 million through a follow on equity offering at CHF 80 per share, a move that directly affects both its growth options and shareholder dilution. See our latest analysis for EPIC Suisse. The fresh capital raise comes on the back of a steady share price return so far this year and a much stronger 1 year total shareholder return of 11.57 percent, suggesting confidence in EPIC Suisse’s long term real estate strategy. If this equity deal has you...

Those holding SIG Group AG ( VTX:SIGN ) shares would be relieved that the share price has rebounded 26% in the last...

Most readers would already be aware that SFS Group's (VTX:SFSN) stock increased significantly by 5.3% over the past...

In order to justify the effort of selecting individual stocks, it's worth striving to beat the returns from a market...

Holcim recently completed two acquisitions and agreed a third in demolition materials recycling across the UK, Germany and France, adding around 1.3 million tons of annual permitted processing capacity to accelerate its ECOCycle® circular construction platform in Europe. By linking these recycling businesses into its existing network, including prior UK and continental European deals, Holcim is deepening local access to circular construction services in major urban and infrastructure...

As the European market navigates mixed performances, with Germany's DAX seeing gains while France's CAC 40 and the UK's FTSE 100 experienced declines, investors are keenly observing economic indicators and central bank policies for cues on future movements. In this climate, identifying stocks that may be trading below their estimated value can offer potential opportunities for those looking to capitalize on market inefficiencies.

Wondering if Kuehne + Nagel International is quietly turning into a value opportunity, or if the recent interest is just noise? Let us unpack what the current share price is really telling you. After a rough stretch that still leaves the stock down 15.3% year to date and 10.5% over the last year, the shares have bounced with gains of 6.5% in the last week and 13.4% over the past month. Those moves come as investors refocus on global trade normalising, ongoing supply chain recalibration after...

Galenica's (VTX:GALE) stock is up by 9.4% over the past three months. As most would know, long-term fundamentals have a...

Partners Group recently reported its Assets under Management as of 31 December 2025 and confirmed it will host a 2025 Business Update and 2026 Outlook presentation on 14 January 2026, offering fresh detail on its operations and plans. This combination of an AuM disclosure and upcoming outlook briefing gives investors a clearer window into how the firm is positioning its private-markets platform for the next phase of growth and product development. We’ll now explore how the latest AuM...

One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will...

Today is shaping up negative for Newron Pharmaceuticals S.p.A. ( VTX:NWRN ) shareholders, with the analysts delivering...

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...

Key Insights Using the 2 Stage Free Cash Flow to Equity, Forbo Holding fair value estimate is CHF1,327 Current share...

If you have been wondering whether Alcon is quietly turning into a bargain or just a value trap, you are not alone. This article is going to unpack what the current share price is really implying. The stock has slipped about 1.6% over the last week but is still up 2.5% over the past month, while longer term returns of about 2.1% over three years and 13.8% over five years show a much slower burn than many investors hoped for after a year to date drop of 17.2% and a 16.1% slide over the last...

Roche Holding (SWX:ROG) just picked up an FDA win for expanded use of its PATHWAY anti HER2 and VENTANA HER2 tests, widening the pool of metastatic breast cancer patients eligible for ENHERTU based on more granular HER2 profiling. See our latest analysis for Roche Holding. That FDA nod slots into a busy few weeks for Roche, with new oncology and diagnostics data out of major conferences and fresh European approvals helping underpin a roughly 24.6% 3 month share price return and 29.8% 1 year...

Key Insights Significant control over Comet Holding by retail investors implies that the general public has more power...

Givaudan (SWX:GIVN) is back in focus after its shares slid more than 5% when management stopped short of reaffirming full year sales growth guidance and flagged tougher market conditions alongside softer than expected Q4 growth. See our latest analysis for Givaudan. That cautious tone has landed on a stock that was already under pressure, with a 1 month share price return of minus 9.63% and a 1 year total shareholder return of minus 22.53%, even though the 3 year total shareholder return is...

As the pan-European STOXX Europe 600 Index experienced a slight decline, with mixed performances across major stock indexes such as Germany's DAX and France's CAC 40, investors are closely watching the European Central Bank's potential policy moves amid resilient economic indicators. In this environment of cautious optimism and potential rate hikes, dividend stocks can offer a reliable income stream for investors seeking stability and growth in their portfolios.

If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...

When we invest, we're generally looking for stocks that outperform the market average. And in our experience, buying...

The simplest way to invest in stocks is to buy exchange traded funds. But investors can boost returns by picking...

Holcim (SWX:HOLN) is back in the spotlight after landing yet another spot on CDP’s A List for climate and water, while also being tagged a top pick by Deutsche Bank. See our latest analysis for Holcim. Against that backdrop, Holcim’s 9.73% 90 day share price return and 70.34% one year total shareholder return suggest momentum is building again, even after a weaker year to date share price. If Holcim’s circular construction push has you thinking about the broader opportunity set, this could be...

Swiss Prime Site (SWX:SPSN) has just wrapped up its CHF 300 million growth push by buying a fully let, modern office property in Zurich West, locking in a 4% net yield with SIX Group as tenant. See our latest analysis for Swiss Prime Site. This latest Zurich West deal lands as the share price sits at CHF 117.9 and builds on solid momentum, with an 18.8% year to date share price return and a strong 3 year total shareholder return of 68.5%. This suggests investors are steadily rewarding the...